Cost varies by compounding pharmacy and whether the injections are bundled with GLP-1 medication, dietary counselling, and prescriber consultations
These findings offer a new therapeutic strategy for this rare, aggressive malignancy and warrant further investigation in larger cohorts
In a 12-month retrospective study of 339 Second Nature members published in JMIR Formative Research, participants on tirzepatide lost an average of 22.1% of their body weight, and those on semaglutide lost 17.1% 5
For these individuals, medications such as Mounjaro or Wegovy may be more effective when used as part of a long-term management strategy rather than a defined short course
Non-surgical weight loss treatment may be suitable for adults with elevated BMI, metabolic challenges, weight-related health risks, or difficulty achieving sustainable weight reduction through lifestyle measures alone